Generics Industry News Search
 |
|
|
|
|
|
|
November 2012 News Archive |
|
|
| |
|
The little blue pill that has enhanced sex lives the world over could face some market competition if the Supreme Court of Canada decides this week that Pfizer Canada's patent on the erectile-dysfunction drug Viagra is invalid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Under the terms of the agreement, Glenmark will launch a generic version of Ortho Tri-cyclen Lo tablets as early as December 31, 2015...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Another month goes by, and another big name pharma brand loses patent protection in India...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Generic drugs firms may start producing versions of Viagra in Canada after a court ruled Pfizer's patent was invalid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it, along with Famy Care, has entered into a settlement agreement with Janssen Pharmaceuticals that will resolve patent litigation related to Norgestimate/Ethinyl Estradiol tablets 0.180 mg/0.025 mg, 0.215 mg/0.025 mg and 0.250 mg/0.025 mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca (AZN) and affiliates will pay as much as $11 million to settle claims the company violated antitrust and consumer-protection laws by keeping generic versions of the heart drug Toprol XL off the mark...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals today announced that its subsidiary Watson Laboratories has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Sildenafil tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced that the Federal Patent Court in Germany has found the formulation patent protecting Seroquel (Quetiapine Fumarate) prolonged-release tablets - marketed as Seroquel Prolong in Germany - to be invalid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its subsidiary Mylan Laboratories has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Sildenafil Citrate tablets, 20 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sagent Pharmaceuticals today announced the launch of Acetazolamide for injection, USP, the generic form of the carbonic anhydrase inhibitor Diamox, in a latex-free vial presentation...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo today announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote (Acetylcysteine) injection brought by Cumberland Pharmaceuticals....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The American Medical Association has come out in favour of legislation to stop deals between branded and generic drug makers that critics blame for delaying entry of generics into the market, according to published reports...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pernix Therapeutics Holdings, a specialty pharmaceutical company, today announced that it has entered into a definitive agreement to acquire Cypress Pharmaceuticals, a privately-owned generic pharmaceutical company, and Hawthorn Pharmaceuticals, a privately-owned branded pharmaceutical company...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Elite Pharmaceuticals announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic equivalent of Bontril PDM 35 mg tablets under the previously announced manufacturing and supply agreement with Mikah Pharma...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced the launch of Rabeprazole in Germany, France, Spain, the Netherlands and UK immediately after the patents expired on 12-13 November...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax Laboratories and its wholly owned subsidiary, ThoRx Laboratories, today confirm that they have initiated a challenge of the patents listed in the Orange Book in connection with Opana...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aceto Corporation, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, will launch the first generic version of the 125 mg and 250 mg strengths of ultramicrosize Griseofulvin tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories announced today that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lupin announced today that it has launched its Fenofibrate tablets, 48 mg and 145 mg strengths in the United States...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Company plans to file petition for rehearing to Supreme Court...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Apotex asked a judge to rule that its plan to market a generic version of the blood-pressure medicine Benicar won't infringe patent rights held by drugmaker Daiichi Sankyo Co. or its American unit...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Impax today announced that it will collaborate with Perrigo on the development, manufacturing and commercialisation of an extended topical generic drug product with first to market potential....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for a divisional patent of Patent Number 8,236,780 "Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies"...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sucampo Pharmaceuticals (SPI) and Abbott (ABT) today announced the availability of Amitza (Lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company today announced that its partner, Cobrek Pharmaceuticals received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Betamethasone valerate foam 0.12%, the generic equivalent of Luxiq foam...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceuticals agreed to delay the introduction of generic versions of two Gilead Sciences HIV drugs until June if a judge hasn't ruled in its favor by then in a patent case brought by Gilead...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Forest Laboratories and Forest Laboratories Holdings (collectively "Forest") announced today that they have entered into settlement agreements with Alkem Laboratories ("Alkem""), Indchemie Health Specialties ("Indchemie"), and Torrent Pharmaceuticals and Torrent Pharma (collectively, "Torrent") in patent infringement litigation brought by Forest in response to abbreviated new drug applications (ANDAs) filed by Alkem, Indchemie and Torrent each seeking approval to market generic versions of Forest's Bystolic (Nebivolol) tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies today announced that its Par Pharmaceutical operating subsidiary has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Olanzapine and Fluoxetine hydrochloride capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tolterodine tartrate tablets, 1 mg and 2 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Policy aims to support a sustainable supply of medically acceptable generic Darunavir in Sub-Saharan Africa (SSA) and Least Developed Countries (LDCs)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Supreme Court on Friday agreed to consider whether generic drug manufacturers can be subjected to personal injury lawsuits that allege flaws in the design of drugs, even if federal law would not allow such cases to go forward...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
